Literature DB >> 22480197

Identification of small molecule inhibitors of the HIV-1 nucleocapsid-stem-loop 3 RNA complex.

Douglas M Warui1, Anne M Baranger.   

Abstract

Stem-loop 3 RNA (SL3) in ψ-RNA is a highly conserved motif in different strains of HIV-1 and serves as a principle determinant for viral packaging. Viral encapsulation is critical for viral replication, and disruption of the nucleocapsid-ψ-RNA complex interferes with viral replication. We have used SL3 RNA as a target for identification of small molecule inhibitors of the interactions of nucleocapsid protein (NCp7) and ψ-RNA. We report the use of computational and high-throughput screening approaches to identify 16 compounds that bind SL3 RNA with micromolar affinities. Among the identified ligands, two molecules, compounds 7 and 17, bind with higher affinity to SL3 RNA than to double- and single-stranded RNAs. Four of the 16 SL3 RNA ligands inhibit interactions between SL3 RNA and NCp7 with micromolar inhibition constants. In general, the identified SL3 ligands have simple molecular structures and low molecular weights and are, therefore, possible lead compounds for the development of ligands that target the elements of ψ-RNA of HIV-1 with high affinity and specificity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22480197     DOI: 10.1021/jm2007694

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  17 in total

1.  Targeting a Novel RNA-Protein Interaction for Therapeutic Intervention of Hantavirus Disease.

Authors:  Nilshad N Salim; Safder S Ganaie; Anuradha Roy; Subbiah Jeeva; Mohammad A Mir
Journal:  J Biol Chem       Date:  2016-10-12       Impact factor: 5.157

Review 2.  Aptamers in HIV research diagnosis and therapy.

Authors:  Jyoti Bala; Srinivasan Chinnapaiyan; Rajib Kumar Dutta; Hoshang Unwalla
Journal:  RNA Biol       Date:  2018-02-12       Impact factor: 4.652

Review 3.  Advances in targeting nucleocapsid-nucleic acid interactions in HIV-1 therapy.

Authors:  Divita Garg; Bruce E Torbett
Journal:  Virus Res       Date:  2014-07-12       Impact factor: 3.303

Review 4.  Telomerase RNA is more than a DNA template.

Authors:  Christopher J Webb; Virginia A Zakian
Journal:  RNA Biol       Date:  2016-05-31       Impact factor: 4.652

Review 5.  Methods to enable the design of bioactive small molecules targeting RNA.

Authors:  Matthew D Disney; Ilyas Yildirim; Jessica L Childs-Disney
Journal:  Org Biomol Chem       Date:  2014-02-21       Impact factor: 3.876

6.  Identification of novel 2-benzoxazolinone derivatives with specific inhibitory activity against the HIV-1 nucleocapsid protein.

Authors:  Elia Gamba; Mattia Mori; Lesia Kovalenko; Alessia Giannini; Alice Sosic; Francesco Saladini; Dan Fabris; Yves Mély; Barbara Gatto; Maurizio Botta
Journal:  Eur J Med Chem       Date:  2017-12-24       Impact factor: 6.514

7.  Genome-Edited Coincidence and PMP22-HiBiT Fusion Reporter Cell Lines Enable an Artifact-Suppressive Quantitative High-Throughput Screening Strategy for PMP22 Gene-Dosage Disorder Drug Discovery.

Authors:  Natalia J Martinez; John C Braisted; Patricia K Dranchak; John J Moran; Hunter Larson; Bryan Queme; Evgenia Pak; Amalia Dutra; Ganesha Rai; Ken Chih-Chien Cheng; John Svaren; James Inglese
Journal:  ACS Pharmacol Transl Sci       Date:  2021-06-10

8.  The N-terminal zinc finger and flanking basic domains represent the minimal region of the human immunodeficiency virus type-1 nucleocapsid protein for targeting chaperone function.

Authors:  Mithun Mitra; Wei Wang; My-Nuong Vo; Ioulia Rouzina; George Barany; Karin Musier-Forsyth
Journal:  Biochemistry       Date:  2013-11-06       Impact factor: 3.162

9.  Development and Implementation of an HTS-Compatible Assay for the Discovery of Selective Small-Molecule Ligands for Pre-microRNAs.

Authors:  Daniel A Lorenz; Steve Vander Roest; Martha J Larsen; Amanda L Garner
Journal:  SLAS Discov       Date:  2017-07-07       Impact factor: 3.341

10.  Enhancement of the physicochemical properties of [Pt(dien)(nucleobase)]2+ for HIVNCp7 targeting.

Authors:  S D Tsotsoros; P B Lutz; A G Daniel; E J Peterson; R E F de Paiva; E Rivera; Y Qu; C A Bayse; N P Farrell
Journal:  Chem Sci       Date:  2016-10-06       Impact factor: 9.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.